CTI BioPharma's IPO

CTI BioPharma raised a round of funding on March 21, 1997. Investors include Public.

CTI BioPharma is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. The company's therapeutic focus is …

Articles about CTI BioPharma's IPO: